Literature DB >> 11377489

Cyclosporine A metabolite AM19 as a potential biomarker in urine for CSA nephropathy.

M Kempkes-Koch1, M Fobker, M Erren, C August, U Gerhardt, B Suwelack, H Hohage.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11377489     DOI： 10.1016/s0041-1345(01)01929-7

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

Review 1.  Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.

Authors:  Christine E Staatz; Lucy K Goodman; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2010-04       Impact factor: 6.447

2.  CYP3A5 gene variation influences cyclosporine A metabolite formation and renal cyclosporine disposition.

Authors:  Songmao Zheng; Yasar Tasnif; Mary F Hebert; Connie L Davis; Yoshihisa Shitara; Justina C Calamia; Yvonne S Lin; Danny D Shen; Kenneth E Thummel
Journal:  Transplantation       Date:  2013-03-27       Impact factor: 4.939

3.  Endomyocardial, intralymphocyte, and whole blood concentrations of ciclosporin A in heart transplant recipients.

Authors:  Ida Robertsen; Pål Falck; Arne K Andreassen; Nina K Næss; Niclas Lunder; Hege Christensen; Lars Gullestad; Anders Asberg
Journal:  Transplant Res       Date:  2013-04-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.